Applied therapeutics to present at the svb securities global biopharma conference

New york, feb. 09, 2023 (globe newswire) -- applied therapeutics, inc. (nasdaq: aplt), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that it will present virtually at the svb securities global biopharma conference on thursday, february 16, 2023 at 2:20 p.m. et.
APLT Ratings Summary
APLT Quant Ranking